Table 1: Demographics of participants both CKD stage G3a-G3b and G4-G5.
Values are mean ± standard deviation where appropriate.
Characteristics | stage G3a-G3b (n=58) | stage G4-G5 (n=46) |
Age (y) | 65.9±11.0 | 68.5±10.8 |
Gender n, (%) |
Male | 38 (65.5) | 24 (52.2) |
Female | 20 (35.5) | 22 (47.8) |
Body weight (kg) | 64.0±13.7 | 60.1±11.9 |
Body mass Index (kg/m2) | 24.4(21.9–26.2) | 23.3±5.8 |
Smoking history n, (%) | 26 (44.8) | 25 (54.3) |
Comorbidity n, (%) |
Diabetes Mellitus | 20 (34.5) | 18 (39.1) |
Hypertension | 40 (70.0) | 38 (82.6) |
Clinical laboratory data |
SBP (mmHg) | 131.8±16.0 | 135.8±16.9 |
DBP (mmHg) | 77.6±12.4 | 72.9±10.2 |
PP (mmHg) | 58.2±14.7 | 62.8±14.6 |
AST (IU/L) | 26.2±15.6 | 20.4±10.0 |
ALT (IU/L) | 22.7±16.7 | 15.2±6.2 |
SUA (mg/dL) | 7.0±1.4 | 7.4±1.6 |
BUN (mg/dL) | 21.9±6.1 | 40.9±14.8 |
SCr (mg/dL) | 1.2±0.3 | 3.1±1.4 |
Ccr (mL/min) | 53.8±17.4 | 19.9±9.3 |
eGFR (mL/min/1.73m2) | 45.2±9.1 | 17.1±6.7 |
TC (mg/dL) | 259.1±95.8 | 243.5±52.5 |
HDL-C (mg/dL) | 51.0±12.5 | 49.3±15.5 |
LDL-C (mg/dL) | 158.7±73.8 | 144±43 |
TG (mg/dL) | 200.4±128.8 | 196.9±91.1 |
Alb (g/dL) | 3.6±0.9 | 3.6±0.5 |
K (mEq/L) | 4.3±0.5 | 4.6±0.6 |
Hb (g/dL) | 13.2±2.0 | 10.7±1.6 |
Ht (%) | 38.5±6.7 | 32.1±6.1 |
HbA1c (NGSP) (%) | 6.4±1.0 | 6.2±0.9 |